Consensus ABIONYX Pharma

Equities

ABNX

FR0012616852

Market Closed - Euronext Paris Other stock markets 11:35:24 2024-04-26 am EDT			5-day change	1st Jan Change
1.024 ^EUR	+0.59%		-4.66%	-20.50%

Mar. 14	Abionyx Pharma: to benefit from a 1ME grant from Bpifrance	CF
Mar. 11	Abionyx: reduced net loss in 2023	CF

Evolution of the average Target Price on ABIONYX Pharma

Price target over the last 5 years

History of analyst recommendation changes

97021a3b552c5f1.Tqi2A0EegM4SXi8ICAwXsoAWT1rJv4U6WAzgllSQJNA.JfeGT3V6sqMgC35eXjxW2OpgKimT7NFWbVaHwTfeU4MdxNtCAFm1tGZmWA~5b71551c4dcd1f294c50da641ca01971

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.024 EUR

Average target price

10.5 EUR

Spread / Average Target

+925.39%

High Price Target

10.5 EUR

Spread / Highest target

+925.39%

Low Price Target

10.5 EUR

Spread / Lowest Target

+925.39%

Consensus detail

Consensus revision (last 18 months)

Ratings for ABIONYX Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar